Literature DB >> 14621275

Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells.

M F Byrne1, J F Murphy, P A Corcoran, J C Atherton, K M Sheehan, D Cox, F E Murray, D J Fitzgerald.   

Abstract

BACKGROUND: Helicobacter pylori induces cyclooxygenase activity in the stomach, although the COX isoform and cellular source are unclear. A potential source is the vascular endothelial cell, which plays a role in regulating mucosal blood flow and inflammatory cell infiltration.
METHODS: We examined the effect of four strains (toxigenic and non-toxigenic) of H. pylori on COX isoform expression in vascular endothelial cells. Prostaglandin synthesis was measured by enzyme immunoassay and COX isozyme expression determined by Western blot and RT-PCR. Gene induction was examined using 5' deletion constructs of the COX-1 and COX-2 promoters coupled with luciferase.
RESULTS: All H. pylori strains induced prostaglandin generation and expression of both COX-1 and COX-2 in HUVEC, although this was most pronounced with the highly toxigenic strain H. pylori 60190. Treatment of the cells with selective COX inhibitors demonstrated that COX-1 was predominantly responsible for the enhanced generation of prostacyclin induced by H. pylori 60190. Similar results were seen with H. pylori broth culture filtrates, suggesting that a secreted product was responsible. Induction of COX-2 reflected both enhanced gene expression and stabilization of the mRNA.
CONCLUSIONS: H. pylori increased both COX-1 and COX-2 activity in vascular endothelial cells. This increased generation of endothelial cell prostacyclin may play a role in modulating mucosal blood flow, platelet function and inflammatory cell infiltration in response to H. pylori infection. The regulation of COX-1 at the transcriptional level by H. pylori described in this study is a novel finding and calls into question the traditional description of COX-1 as a purely constitutive, housekeeping gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621275     DOI: 10.1080/00365520310005622

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

Review 1.  Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.

Authors:  Bei Wang; Lujin Wu; Jing Chen; Lingli Dong; Chen Chen; Zheng Wen; Jiong Hu; Ingrid Fleming; Dao Wen Wang
Journal:  Signal Transduct Target Ther       Date:  2021-02-26

2.  Polymorphisms within inflammatory genes and colorectal cancer.

Authors:  Stefano Landi; Federica Gemignani; Fabio Bottari; Lydie Gioia-Patricola; Elisabet Guino; María Cambray; Sebastiano Biondo; Gabriel Capella; Laura Boldrini; Federico Canzian; Victor Moreno
Journal:  J Negat Results Biomed       Date:  2006-10-24

Review 3.  Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications.

Authors:  Junjian He; Yunyi Liu; Qin Ouyang; Rongxing Li; Jie Li; Weiyan Chen; Weichao Hu; Lijiao He; Qiyu Bao; Ping Li; Changjiang Hu
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

Review 4.  Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?

Authors:  Mohamed Riad
Journal:  Egypt Heart J       Date:  2021-07-03

5.  Association of helicobacter pylori infection with severity of coronary heart disease.

Authors:  Mehran Rogha; Davood Dadkhah; Zahra Pourmoghaddas; Keivan Shirneshan; Marjan Nikvarz; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.